IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3060% above fair value
$85.35+0.12 (+0.14%)
Close on Nov 13, 2026Market cap $1.09BP/E 45.6Yield –
IRadimed operating margin
Operating margin is operating income as a percentage of revenue.
IRadimed's operating margin for the twelve months ending Sep 30, 2026 was 32.3%. For fiscal 2025 it was 31.2%, against 30.0% the year before. The highest annual figure on record is 36.4% in fiscal 2015.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 31.2% | +1.2 |
| FY2024 | Dec 31, 2024 | 30.0% | −0.6 |
| FY2023 | Dec 31, 2023 | 30.6% | +1.2 |
| FY2022 | Dec 31, 2022 | 29.3% | +5.8 |
| FY2021 | Dec 31, 2021 | 23.5% | +25.9 |
| FY2020 | Dec 31, 2020 | -2.4% | −24.8 |
| FY2019 | Dec 31, 2019 | 22.5% | +2.7 |
| FY2018 | Dec 31, 2018 | 19.7% | +14.2 |
| FY2017 | Dec 31, 2017 | 5.6% | −28.0 |
| FY2016 | Dec 31, 2016 | 33.6% | −2.8 |
| FY2015 | Dec 31, 2015 | 36.4% | +16.9 |
| FY2014 | Dec 31, 2014 | 19.6% | −5.0 |
| FY2013 | Dec 31, 2013 | 24.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 33.6% | +1.4 |
| Q2 FY2026 | Jun 30, 2026 | 31.2% | −2.0 |
| Q1 FY2026 | Mar 31, 2026 | 32.9% | +5.1 |
| Q4 FY2025 | Dec 31, 2025 | 31.3% | +1.3 |
| Q3 FY2025 | Sep 30, 2025 | 32.2% | +0.6 |
| Q2 FY2025 | Jun 30, 2025 | 33.3% | +1.9 |
| Q1 FY2025 | Mar 31, 2025 | 27.8% | +0.9 |
| Q4 FY2024 | Dec 31, 2024 | 29.9% | +0.4 |
| Q3 FY2024 | Sep 30, 2024 | 31.6% | −4.2 |
| Q2 FY2024 | Jun 30, 2024 | 31.4% | +0.6 |
| Q1 FY2024 | Mar 31, 2024 | 27.0% | +1.1 |
| Q4 FY2023 | Dec 31, 2023 | 29.6% | +0.9 |
| Q3 FY2023 | Sep 30, 2023 | 35.8% | +5.0 |
| Q2 FY2023 | Jun 30, 2023 | 30.8% | −2.0 |
| Q1 FY2023 | Mar 31, 2023 | 25.9% | +0.9 |
| Q4 FY2022 | Dec 31, 2022 | 28.6% | +2.4 |
| Q3 FY2022 | Sep 30, 2022 | 30.8% | +2.5 |
| Q2 FY2022 | Jun 30, 2022 | 32.8% | +14.0 |
| Q1 FY2022 | Mar 31, 2022 | 25.0% | +5.7 |
| Q4 FY2021 | Dec 31, 2021 | 26.2% | +18.6 |
| Q3 FY2021 | Sep 30, 2021 | 28.3% | +18.1 |
| Q2 FY2021 | Jun 30, 2021 | 18.8% | +61.9 |
| Q1 FY2021 | Mar 31, 2021 | 19.3% | +10.8 |
| Q4 FY2020 | Dec 31, 2020 | 7.6% | −12.9 |
| Q3 FY2020 | Sep 30, 2020 | 10.2% | −15.1 |
| Q2 FY2020 | Jun 30, 2020 | -43.1% | −68.9 |
| Q1 FY2020 | Mar 31, 2020 | 8.5% | −9.4 |
| Q4 FY2019 | Dec 31, 2019 | 20.6% | −0.9 |
| Q3 FY2019 | Sep 30, 2019 | 25.3% | +6.3 |
| Q2 FY2019 | Jun 30, 2019 | 25.8% | +3.0 |
| Q1 FY2019 | Mar 31, 2019 | 17.9% | +2.6 |
| Q4 FY2018 | Dec 31, 2018 | 21.5% | +6.6 |
| Q3 FY2018 | Sep 30, 2018 | 19.0% | +15.6 |
| Q2 FY2018 | Jun 30, 2018 | 22.7% | +16.8 |
| Q1 FY2018 | Mar 31, 2018 | 15.3% | +19.9 |
| Q4 FY2017 | Dec 31, 2017 | 14.9% | −10.2 |
| Q3 FY2017 | Sep 30, 2017 | 3.4% | – |
| Q2 FY2017 | Jun 30, 2017 | 5.9% | – |
| Q1 FY2017 | Mar 31, 2017 | -4.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 25.1% | – |
See a number that looks wrong?